- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
Related Products
|
Granulocyte-macrophage colony-stimulating factor (GM-CSF), encoded by the CSF2 gene, is a secreted cytokine that plays a central role in immune regulation, hematopoiesis, and inflammatory signaling. GM-CSF Antibody / CSF2 Microarray Specificity Validated Antibody (clone CSF2/3403) is designed as a high-confidence reference reagent for detection of GM-CSF, combining biochemical validation with proteome-wide specificity assessment. GM-CSF antibody, also referred to as CSF2 antibody or granulocyte macrophage colony-stimulating factor antibody in the literature, is widely used in studies of immune activation, cytokine signaling, and inflammatory disease. This antibody is part of a collection of Human Protein Microarray validated antibodies that have been screened for specificity across thousands of proteins.
GM-CSF is produced by a variety of cell types, including T lymphocytes, macrophages, endothelial cells, and fibroblasts, particularly in response to immune stimulation. It functions as a key regulator of myeloid cell development, promoting the proliferation and differentiation of granulocytes and macrophages from hematopoietic progenitors. In addition to its role in hematopoiesis, GM-CSF enhances the functional activity of mature immune cells, including antigen presentation, phagocytosis, and cytokine production.
Functionally, GM-CSF acts through its receptor to activate downstream signaling pathways such as JAK-STAT, MAPK, and PI3K pathways, leading to transcriptional programs that support immune cell survival and activation. These signaling cascades are critical in both normal immune responses and pathological conditions, including chronic inflammation, autoimmune disease, and cancer-associated immune modulation.
As a secreted protein, GM-CSF is typically detected in extracellular compartments, conditioned media, or within producing cells depending on the assay and experimental context. In immunohistochemistry, staining may be observed in immune cell populations and stromal cells within inflamed or tumor-associated tissues, often with cytoplasmic localization corresponding to cytokine production.
A defining feature of this antibody is its validation using protein microarray analysis across thousands of human proteins, demonstrating selective binding to GM-CSF with minimal off-target interaction. This provides strong evidence of specificity and supports its use as a reference antibody for accurate detection of CSF2 in complex biological samples.
The mouse monoclonal clone CSF2/3403 antibody provides reliable and specific detection of GM-CSF in research applications. Its combination of microarray-confirmed specificity and robust performance in multiple assay formats makes it well suited as an anchor antibody for studies of immune signaling, cytokine biology, and inflammatory regulation.
The concentration stated for each application is a general starting point. Variations in protocols, secondaries and substrates may require the GM-CSF Antibody / CSF2 Microarray Specificity Validated Antibody to be titered up or down for optimal performance.
Recombinant human protein was used as the immunogen for this GMCSF antibody.
Store the GMCSF antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).
GM-CSF antibody, CSF2 antibody, Granulocyte macrophage colony stimulating factor antibody, GMCSF protein antibody, Colony stimulating factor 2 antibody
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.